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Study objective: To evaluate the safety of high-dose IV 
narcotics in patients requiring analgesia for painful emergency 
department procedures. 
Design: Prospective multicenter clinical trial. 
Setting: Five adult urban EDs. 
Methods and measurements: All patients received IV 
meperidine (1.5 to 3.0 mg/kg)titrated to analgesia followed by a 
painful procedure. Vital signs and alertness scale were recorded 
at regular intervals, and patients were observed for four hours. 
Adverse events were monitored and documented. Comparisons 
between baseline and postanalgesia intervals were made with 
a repeated measures ANOVA (Dunnett's test). 
Results: Although statistically significant changes in vital signs 
and alertness scale occurred, they were not clinically significant. 
Opiate reversal with naloxone was not needed in any patient, 
and no significant respiratory or circulatory compromise 
occurred. 
Conclusion: This study of 72 patients demonstrates that high- 
dose narcotic analgesia is appropriate, well tolerated, and safe 
when used in selected patients before painful procedures in 
the ED. Narcotic antagonists and resuscitation equipment 
nonetheless should be available to maximize safety. 
[Barsan WG, Tomassoni A J, Seger D, Danzl DF, Ling L J, Bartlett R: 
Safety assessment of high-dose narcotic analgesia for emergency 
department procedures. Ann Emerg Med September 
1993;22:1444-1449.] 
1 0 2 /1  444 ANNALS OF EMERGENCY MEDICINE 22:9 SEPTEMBER 1993 
NARCOTIC ANALGESIA 
Barsan et aI 
INTRODUCTION 
Opiate compounds are used frequently in the emergency 
department to facilitate the performance of painful proce- 
dures by reducing the pain and anxiety experienced 
by patients. Despite the availability of potent opiate 
compounds for the relief of pain, studies suggest that sub- 
stantial numbers of adult and pediatric patients are under- 
medicated for the degree of pain experienced. 1-5 Pear of 
dangerous adverse effects, especially respiratory depres- 
sion, is an important factor that apparently prevents the 
use of adequately dosed narcotic analgesia. 
No prospective studies have documented the safety of 
appropriately "high-dose" IV narcotics for procedures in 
the ED. As a result, patients frequently are given subthera- 
peutic doses of narcotics for painful procedures, and 
analgesia is supplemented by "brutane" (ie, insufficient 
analgesia followed by the necessarily aggressive perfor- 
mance of a procedure). In a retrospective review of 2,000 
pediatric cases of facial trauma in which the patients 
were sedated with IV fentanyl, Billmire et al 6 reported 
only three cases of apnea requiring antagonist reversal. 
They concluded that fentanyl is a safe and useful adjunct 
to the treatment of pediatric facial trauma. Similarly, 
Chudnofsky et al 7 retrospectively reviewed 841 cases in 
which fentanyl was used without serious complication in 
an adult population. No patient required hospitalization 
for complications in either study. 
Intersubject variability in opiate requirements must be 
recognized. Patient weight is only one of many variables 
that influence opiate requirements. Older patients 
demonstrate increased responses to therapeutic doses of 
meperidine, thought to be the result of decreased protein 
binding and increased plasma concentrations. 8 Several 
variables are known to alter the pain threshold, including 
sex, alterations in circulation, skin temperature, sweating, 
Pco2, and anxiety, fear, and other emotions. A given 
subject may have unequal responses to identical doses of 
a given narcotic at different times. # Interethnic variability 
in doses of meperidine required to produce analgesia also 
have been described, lo 
We conducted a prospective study in patients receiving 
aggressive doses of IV meperidine in the ED for painful 
procedures to evaluate the effects on vital signs and 
alertness and to document adverse outcomes. 
MATERIALS AND METHODS 
All patients were participants in a multicenter study com- 
paring two opiate antagonists with placebo in reversing 
the effects of IV narcotics given to obtain analgesia for' 
time-limited painful procedures.ll Seventy patients who 
received high-dose meperidine followed by placebo 
(normal saline IV) for narcotic reversal were the subjects 
of this study. 
All patients were between 18 and 65 years old and 
had conditions for which opiate analgesia was indicated 
(ie, performance of a painful procedure), including joint 
reduction, incision and drainage of an abscess, or dilata- 
tion and curettage for an incomplete abortion. Informed 
consent was obtained from all patients before entry in the 
study. This study was approved by the institutional review 
boards of all participating institutions. 
Patients with a history of allergy to opiates or narcotic 
antagonists and all pregnant or lactating women were 
excluded. Other exclusions were recent history of sub- 
stance abuse, recent ingestion of sedating drugs including 
opiates (within four half-lives), psychiatric or neurologic 
impairment, baseline alertness scale score of 19 or less, 
head injury, and active liver or cardiorespiratory disease. 
Patients with severe chronic obstructive pulmonary disease 
or congestive heart failure were specifically excluded as 
were patients on clonidine, c~-methyldopa, or guanabenz 
for hypertension. Patients who were likely to require 
opiates for ongoing pain control were excluded also. 
A history and physical examination were performed 
on all patients before en t~  Peripheral IV access was 
secured. Baseline vital signs and alertness scale then were 
determined (Table 1). Opiate analgesia was obtained with 
IV meperidine administered over 15 minutes to a dose of 
1.5 to 3.0 mg/kg, not to exceed 300 mg. Meperidine was 
administered in bouses of 25 to 50 mg with incremental 
titration until there was adequate analgesia and sedation 
based on the physicians' clinical assessment. Vital signs 
(temperature, pulse, respirations, and blood pressure) 
and alertness scale were repeated. The painful procedure 
was performed and completed within a 45-minute period. 
After the procedure, each patient received 1.0 mL IV 
normal saline as placebo based on preassigned random 
codes. Vital signs and alertness scales then were repeated 
every 15 minutes for one hour and every 30 minutes 
for the subsequent three hours. Patient follow-up was 
obtained in 24 to 72 hours. 
The alertness scale used was adapted from previously 
designed and tested scales. It consists of four parts 
(Table 1). The eye opening and speech scores were adapted 
from the Glasgow Coma Scale. Level of consciousness 
was adapted from the Head Injury Watch Sheet, and the 
commands section was adapted from the Edinburgh-2 
Coma Scale. Each of the categories in level of conscious- 
ness, eye opening, and speech sections of the scale was 
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assigned two points to allow for gradation of response. 
For example, a patient who responded to conversational 
tones of voice would score five points, whereas a patient 
who responded solely to shouting would score only four 
points. 
Values obtained for respiratory rate, systolic and 
diastolic blood pressure, pulse rate, temperature, and alert- 
ness scale after the administration of narcotic analgesia 
were compared with baseline values using a repeated 
measures ANOVA (Dunnett's test). All variables were tested 
to ascertain if their distributions could be considered 
normally distributed for ANOVA calculations. Only the 
commands section of the alertness scale was determined 
to be significantly non-normal, acting essentially as a con- 
stant in the total alertness score. When the alertness scale 
is adjusted by deleting the commands section, the results 
are almost identical, a was set at .05; therefore, values of 
P < .05 were considered statistically significant. 
R E S U L T S  
Seventy patients, 39 men and 31 women, ranging in age 
from 18 to 63 years were enrolled in this study. The mean 
age was 31.1 years. The mean dose of meperidine given to 
these patients was 173 mg (75 to 310 rag), corresponding 
to a mean dose of 2.5 mg/kg. The mean time between 
analgesia and completion of the painful procedure was 
24 minutes. No procedure lasted longer than one hour. 
Diagnoses of the 209 patients admitted to all arms of the 
study consisted of soft tissue abscess (72%), dislocated 
joints (12%), incomplete abortions (8%), and other (8%) 
Table 1. 
Alertness scale 
















Awakens to voice 
Awakens to shaking 





Clear, spontaneous, appropriate 
Clear, appropriate, not spontaneous 
Inappropriate but can say one word 
Incomprehensible, garbled, slurred 
Commands (open/close hands; open/close eyes) 
4 Both correct 
2 One correct 
0 Both incorrect 
including painful joint injury, burns, lacerations, and 
thrombosed hemorrhoids. 
Thirteen adverse reactions occurred among patients 
in the placebo arm of the study (Table 2). No patients 
required naloxone reversal for severe respiratory depres- 
sion or other indication. No respiratory br cardiac arrests 
occurred, and no patients required ventilatory assistance, 
intubation, or CPR. Nausea and vomiting were occasional- 
ly noted. Follow-up visits in 24 to 72 hours revealed no 
significant late side effects. 
Respiratory rate dropped from a mean baseline of 
20 + 4.2 breaths per minute to a mean nadir of 17 + 3.3 
breaths per minute at 15 minutes after the termination 
of the procedure (P < .05). The lowest respiratory rate at 
any time in any patient was ten, and no patient required 
vendlatory assistance or reversal with a narcotic antagonist. 
The four-hour postprocedure respiratory rate was 18 + 3 
breaths per minute (P < .05). 
The mean nadir systolic blood pressure (after meperi- 
dine) occurred at one and two hours after the termination 
of the painful procedure and was 123 + 14 mm Hg and 
123 + 14 mm Hg (P <.05), respectively. The greatest 
individual drop in systolic blood pressure compared with 
the baseline measurement was 56 mm Hg, from 180 to 
124 mm Hg one hour after the painful procedure. The 
lowest recorded systolic pressure was 88 mm Hg in a 
patient whose initial reading was 90 mm Hg. The four- 
hour postprocedure mean systolic blood pressure was 
125 mm Hg for comparison with the baseline value of 
131 mm Hg (not statistically significant). 
The baseline mean diastolic blood pressure was 
82 + 13 mm Hg, and the mean nadir diastolic blood pres- 
sure (after meperidine) was 77 + 11 mm Hg (P <.05 ) 
15 minutes after the procedure and 77 + 12 mm Hg (not 
statistically significant at the P <.05 level) at 30 minutes 
after completion of the painful procedure. At four hours 
Table 2. 
Type and frequency of complications encountered with the use of 
high-dose meperidine 






Other *t  1 
*Includes palpitations, sweating, tachycardia, tinnitus paresthesia, tremor, vasodilation, or 
vertigo. 
tNo chest pain, paranoia, dyspepsia, chills, or nervousness were noted. 
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after the procedure, the mean diastolic blood pressure 
measured 77 + 12 mm Hg (not statistically different from 
control). 
Mean pulse rate before administration of meperidine 
was 83 + 16. Mean nadir pulse rates occurred at both 120 
and I80 minutes after the end of the procedure and were 
identical at 73 + 13 (P < .05). After meperidine, the low- 
est measured pulse rate was 41 in a patient whose base- 
line rate was 45. No patient required fluids or drug treat- 
ment for hypotension or bradycardia. At four hours after 
the procedure, the mean pulse rate was 74 + 13 (P < .05). 
A clinically insignificant decrease in body temperature 
(less than 1.0 C) was noted. This is consistent with the 
established knowledge that narcotic administration may 
influence temperature in human beings, i2 
All patients had a baseline alertness score of 25 of a 
possible 25 points, except for one who began with a 
baseline score of 24. After administration of meperidine, 
patients were notably sedated; however, the lowest level 
of alertness in any patient was 13 of 25. Mean nadir alert- 
ness score was 19 + 2.7 points (P < .05) immediately after 
analgesia. The mean alertness score remained at its nadir 
until the end of the procedure and improved steadily 
thereafter. The mean alertness scale score at four hours 
was 24 + 2.0 (P < .05). All patients were discharged after 
the four-hour observation without any reported complica- 
tions after discharge. Only the commands section of the 
alertness scale showed significant non-normality, acting 
essentially as a constant. 
DISCUSSION 
Parenteral narcotic analgesia has been the standard for 
providing pre- and postoperative pain relief in the hospi- 
talized patient since the invention of the hollow needle 
and syringe in 1853. Meperidine was synthesized first in 
1939 and initially enjoyed popularity as an anesthetic in 
conjunction with nitrous oxide. ~3 It is approximately one- 
eighth to one-tenth as potent as morphine. Meperidine 
often is selected because of its intermediate duration of 
action, oral availability, and less resultant spasmogenicity 
when compared with other opiates (excluding the agonist- 
antagonist class of opiates). It is suitable for the 
performance of painful procedures and postprocedure 
analgesia, with the exception of bronchoscopy where its 
relative lack of antitussive effect makes it less desirable 
than other opiates. Jaffe and Martin 12 stated that physi- 
cians often prescribe doses of meperidine that are too low 
or too infrequent, thereby causing needless suffering. 
IM use of meperidine results in variable pain control 
within a given subject when studied at regular dosing 
intervals. This effect is due to two variables: unpredictable 
absorption from the IM site and large interpatient vari- 
ability between blood meperidine concentration and 
analgesic effect. In addition, the dose-response curve for 
meperidine is steep, with small increases in blood meperi- 
dine concentration producing a dramatic effect on analge- 
sia. Elimination of the absorption step by IV administra- 
tion and titration of drug levels in response to pain rather 
than strict adherence to body weight dosing may be 
expected to yield improved analgesia. >,15 
Physician and patient attitudes regarding assessment 
and expression of pain along with fear of opioid depen- 
dence are often based on fallacious reasoning. These 
factors must be overcome to provide effective pain 
management. Improved understanding of narcotic depen- 
dency, tolerance, patient behavior, prescribing errors, 
analgesic equivalencies, and effect of route of administra- 
tion should facilitate effective pain management. Frequent 
reinforcement of the hazards associated with narcotic 
administration and too little teaching about proper use of 
these agents, potential misunderstanding of equianalgesic 
doses of different narcotics, and apprehension on the part 
of nurses and other staff may further contribute to the 
high incidence of oligoanalgesia, especially in the litigious 
climate surrounding medicine today.3,~< 17 
In a study with some parallels to ours, a clinical neuro- 
logic and behavioral scoring system developed for assess- 
ment of pain in infants facilitated use of narcotic analgesia 
in this group historically undertreated for pain. No signifi- 
cant differences were noted between those receiving 
3 gg/kg fentanyl and controls with respect to transcuta- 
neous Po 2 or Pco 2, oxygen saturation, blood pressure, 
heart rate, or temperature. A faster respiratory rate was 
noted in controls. This was attributed to pain. is 
Although statistically significant differences in vital 
signs and alertness scale were evident, there were no 
episodes of airway compromise, respiratory arrest, or 
hemodynamic instability. The modest declines in four- 
hour blood pressure values, pulse rates, and respiratory 
rates compared with baseline might reflect a decrease in 
the level of the patients' pain and apprehension after the 
correction of their underlying medical problem. Maximal 
respiratory depression occurred at 15 minutes after the 
painful procedure in most patients, a point when narcotic 
blood level is still high and pain and anxiety have been 
decreased because of correction of the underlying medical 
problem. This finding supports the premise that extended 
observation in the ED after narcotic analgesia may not be 
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warranted solely because of fear of respiratory depression. 
No instance of respiratory depression or rebound adverse 
effect after discharge was reported by patients on question- 
ing at follow-up. Regarding other vital signs, systolic 
blood pressure reached a nadir at 120 minutes, diastolic 
blood pressure at 60 minutes, and pulse at both 120 and 
180 minutes, with no patient becoming hemodynamically 
unstable or requiring resuscitation. The individual nadir 
respiratory rate of ten breaths per minute (obtained at 
termination of the painful procedure) further supports 
the contention that observation periods in the ED may be 
shortened even with high-dose meperidine administration. 
The placebo effect was not controlled for in this sub- 
population from a larger study Similarly, the effect of 
placebo in this control arm of a larger study of 209 
patients (in place of nalmefene) is an extraneous variable 
whose effect, although presumed to be small, is unknown. 
Two complications were noted in the larger study. Neither 
patient belonged to the study arm from which our data 
were derived. One patient in the larger study had poten- 
tially dangerous respiratory depression, received unblinded 
naloxone, and was not included in any study data. A 
second patient received naloxone for an inadvertent 
overdose of 200 mg of meperidine fast IV push and was 
likewise not included in the study data. 
Where used episodically in the ED for the performance 
of a painful procedure, narcotic abuse potential and 
liability are not likely to be of concern except perhaps in 
the reformed addict. Safety dictates that absolute and 
relative contraindications to the use of meperidine must 
be recognized (Figure). Narcotic administration may cause 
nausea and vomiting, increasing the risk of aspiration of 
gastric contents in patients who have eaten shortly before 
sedation. Increased potential for adverse effects must be 
recognized when narcotic adjuncts such as benzo- 
diazepines are used in conjunction with narcotics. 
Frequent evaluation of vital signs and alertness coupled 
with ECG and oxygen saturation monitors should be 
standard wherever conscious sedation is used to improve 
the margin of safety for patients receiving large doses of 
narcotics and other sedative medications. A narcotic 
antagonist such as naloxone and standard advanced 
cardiac life support resuscitation equipment should be 
available along with personnel skilled in the use of these 
materials for patient protection in the event of inadvertent 
overdose. 
Clinically unrecognized hypoxemia has been docu- 
mented during cortscious sedation in patients monitored 
by pulse oximeter. Properly set audible alarms on moni- 
toring equipment are essential to prevent unrecognized ' 
respiratory or circulatory collapse in unsupervised 
patients after the procedure, when reduction in the 
magnitude of painful stimuli may depress their mental 
status and vital signs. Unfortunately, at the time of this 
study, pulse oximetry was not widely available in the ED. 
Capnography by nasal cannula also is iandergoing study 
in this setting, allowing the monitoring of both end-tidal 
Pco 2 and respiratory patterns. Although capnometers are 
not generally available in EDs at this time, improvements 
in clinical care coupled with technologic advancement 
may virtually mandate their future use during conscious 
sedation. 19 
The established practice of observing patients for 
two to four hours to ensure safe discharge from the ED 
after the administration of potentially sedating doses of 
narcotics may be a deterrent to the administration of 
narcotic analgesia in a busy ED setting. Fear of rebound 
respiratory depression may be a contributing factor and 
may contribute to the avoidance of adequate dose anal- 
gesia. With additional study to demonstrate the safety of 
conscious sedation using short-acting drugs in adequate 
therapeutic doses, observation time might be decreased. 
Short-acting narcotics such as fentanyl (another phenyl- 
piperadine congener of meperidine), sufentanil, or alfen- 
tanil may soon become the standard of care for conscious 
sedation in outpatient settings. Alternatively, the introduc- 
tion of a narcotic antagonist similar to nalmefene may 
provide the impetus for physicians to use adequate dose 
analgesia for the performance of painful procedures in the 
outpatient setting with the assurance that a reliable long- 
acting narcotic reversal agent can provide. 11 Our work 
suggests that a two-hour interval may be sufficient obser- 
vation time for many patients. Patients may be discharged 
when they are awake and alert without clinical signs of 
sedation or respiratory depression. It is our practice to 
Figure. 
Absolute and relative contraindications to meperidine 
Hypersensitivity 
Head injury and increased intracranial pressure 
Asthma, chronic obstructive pulmonary disease, or pre-existing respiratory 
depression 
Congestive heart failure or ischemic cardiac disease 
Pre-existing hypatension 




History of tachyarrhythmias 
Conditions causing delayed drug metabolism and clearance 
{especially liver disease) 
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discharge patients to the care of a family member or 
similar caretaker with instructions to avoid driving and 
other potential hazards, including the consumption of 
alcohol and other depressant drugs for a period equal 
to several half-lives of the narcotic administered. 
CONCLUSION 
Although the administration of large doses of meperidine 
produced statistically significant changes in respiratory 
rate, blood pressure, and pulse rate, these changes were 
not clinically significant. Changes in alertness score 
reflected analgesia and sedation sufficient to allow the 
performance of a painful procedure but reverted back to 
baseline thereafter without clinically significant sequelae 
at any time. We conclude that appropriately high doses 
of meperidine are well tolerated and safe when given to 
patients without significant cardiorespiratory disorders or 
other contraindications before painful procedures in the ED. 
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